didanosine
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AF - Nucleoside And Nucleotide Reverse Transcriptase Inhibitors -> J05AF02 - Didanosine
Administration category:
Free
Medicine group:
antiviral
Brand name:
Videx
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
| < 60 kg | |||
|
ROA: po |
Load: - |
Dosage: 250mg 1 dd |
|
| ≥ 60 kg | |||
|
ROA: po |
Load: - |
Dosage: 400mg 1 dd |
|
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 30 - 50 |
Dosage: bij lichaamsgewicht > 60 kg 200 mg per dag, bij lichaamsgewicht < 60 kg 150 mg 1 dd po |
|||
|
GFR: 10 - 30 |
Dosage: bij lichaamsgewicht > 60 kg 150 mg per dag, bij lichaamsgewicht < 60 kg 100 mg 1 dd po |
|||
|
GFR: <10 |
Dosage: 100 mg 1 dd po |
|||
Renal elimination:
20%
Dosage:
dependent on kidney function
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-1878.1
Updated: 06/16/2019 - 20:05
Status: Published